Shuttle pharmaceuticals inc stock
WebAug-30-22 04:40PM. Shuttle Pharmaceuticals Announces Pricing of Initial Public Offering. PR Newswire. Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy.
Shuttle pharmaceuticals inc stock
Did you know?
WebApr 10, 2024 · A high-level overview of Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. WebThe Company was originally founded as Shuttle Pharmaceuticals, LLC in December 2012 in the State of Maryland. In June 2024, Shuttle Pharmaceuticals, Inc. became a wholly owned subsidiary of Shuttle Pharmaceuticals Holdings, Inc., a State of Delaware corporation.
WebAt Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life. WebFind real-time SHPH - Shuttle Pharmaceuticals Holdings Inc stock quotes, company profile, news and forecasts from CNN Business.
WebApr 7, 2024 · Shuttle Pharmaceuticals Holdings Inc’s trailing 12-month revenue is $0.0 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. There are not analysts providing consensus earnings estimates for the current fiscal year. Shuttle Pharmaceuticals Holdings Inc does not currently pay a dividend. WebShuttle Pharmaceuticals Holdings Inc is a clinical stage pharmaceutical company leveraging our proprietary technology to develop novel therapies designed to cure cancers. The company's goal is to extend the benefits of cancer treatments by leveraging insights into the pillars of cancer therapy: surgery, radiation therapy, chemotherapy, and ...
WebMar 17, 2024 · Shuttle Pharmaceuticals Holdings, Inc., through its subsidiary, Shuttle Pharmaceuticals, Inc., focuses on the discovery, development, and commercialization of drugs for sensitizing cancers to radiation therapy. Its products in clinical stage include Ropidoxuridine, an oral halogenated pyrimidine to treat patients with brain tumors and …
WebCompany profile page for Shuttle Pharmaceuticals Inc including stock price, company news, press releases, executives, board members, and contact information opening ris filesWebFind real-time SHPH - Shuttle Pharmaceuticals Holdings Inc stock quotes, company profile, news and forecasts from CNN Business. iow pearlWebFind the latest Shuttle Pharmaceuticals Holdings, Inc. (SHPH) stock quote, history, news and other vital information to help you with your stock trading ... climbed 160.4% this week, according to data from S&P Global Intelligence. The stock closed at $14.90 last Friday and then opened this Tuesday at $12.16. The stock began trading on Aug. 31 ... iow pearl centreWebApr 6, 2024 · Shuttle Pharmaceuticals Holdings, Inc. (SHPH) NASDAQ: SHPH · IEX Real-Time Price · USD. Add to Watchlist 1.39-0.06 (-4.14%) At close: Apr 6, 2024, 4:00 PM. 1.38 ... No financial forecasts available for this stock Revenue Forecast. No data available. Revenue Growth. No data available. EPS Forecast. No data available. opening rn postionWebShuttle Pharmaceuticals Provides Fiscal Year 2024 Corporate Update. Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company ... opening roof specialists melbourneWebSep 6, 2024 · PR Newswire. ROCKVILLE, Md., Sept. 6, 2024 /PRNewswire/ -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on ... iow parkdeanWebDiscover historical prices for SHPH stock on Yahoo Finance. View daily, weekly or monthly format back to when Shuttle Pharmaceuticals Holdings, Inc. stock was issued. opening roof specialists sydney